|
Liu, H; Vuyyuru, V B; Pham, C D et al. (1999) Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association. Oncogene 18:3461-70
|
|
Pham, C D; Vuyyuru, V B; Yang, Y et al. (1999) Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos. Oncogene 18:4287-94
|
|
Yang, Y; Pham, C D; Arlinghaus, R B et al. (1998) Elevated level of cyclin D1 in mos-transformed cells. Int J Oncol 12:1199-202
|
|
Yang, Y; Pham, C D; Vuyyuru, V B et al. (1998) Evidence of a functional interaction between serine 3 and serine 25 Mos phosphorylation sites. A dominant inhibitory role of serine 25 phosphorylation on Mos protein kinase. J Biol Chem 273:15946-53
|
|
Singh, B; Arlinghaus, R B (1997) Mos and the cell cycle. Prog Cell Cycle Res 3:251-9
|
|
Gao, C; Arlinghaus, R B; Singh, B (1996) Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells. Oncogene 12:1571-6
|
|
Yang, Y; Herrmann, C H; Arlinghaus, R B et al. (1996) Inhibition of v-Mos kinase activity by protein kinase A. Mol Cell Biol 16:800-9
|
|
Pham, C D; Arlinghaus, R B; Zheng, C F et al. (1995) Characterization of MEK1 phosphorylation by the v-Mos protein. Oncogene 10:1683-8
|
|
Bai, W; Arlinghaus, R B; Singh, B (1993) Association of v-Mos with soluble vimentin in vitro and in transformed cells. Oncogene 8:2207-12
|
|
Bai, W; Singh, B; Yang, Y et al. (1992) Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk. Oncogene 7:1757-63
|
Showing the most recent 10 out of 26 publications
